Clinical Trial Update: Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants [Phase 4]

View source ↗

Summary

Phase 4 trial update of Auryxia (ferric citrate) for in-center and home dialysis patients with hyperphosphatemia, anemia, or iron deficiency; study status compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hyperphosphatemia
• Iron Deficiency Anemia
• Renal Insufficiency

Drugs mentioned

• Auryxia (ferric citrate)

Snippet

Sponsor: USRC Kidney Research | Conditions: Hyperphosphatemia, Anemia, Iron Deficiency | Phase 4 | Status: COMPLETED